Hypoxia, Brain: Clinical Trials

42 trials for Hypoxia, Brain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 8 recruiting, 4 not yet recruiting, 3 terminated. 42 Phase 2, 16 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 242Completed 22, Recruiting 8, Not yet recruiting 4, Terminated 3, Unknown 2, Withdrawn 2, Active not recruiting 1
Phase 116Completed 10, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1

Follow Hypoxia, Brain: new trials by email Literature Review of Hypoxia, Brain trials Research Report on Hypoxia, Brain

Trials (filtered) newest first · largest first

All 42 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia
Phase 2 / Phase 3Not yet recruitingUMC Utrecht1622027-04-012026-09-21
The PROTECT-HIE Pilot Trial
Dobutamine, TnECHO - Hypoxic-ischemic Encephalopathy (HIE)
Phase 2RecruitingUniversity of Alberta402026-10-132026-11-05
Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy
Sildenafil Citrate (IV) - Hypoxic-Ischemic Encephalopathy
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris242026-10-012026-03-31
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
Wharton's jelly-derived mesenchymal stem cells, 0.9 % Normal Saline - Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic
Phase 1 / Phase 2Not yet recruitingMahidol University402026-09-152026-09-02
EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES
Melatonin, intravenous (IV) fluids, intensive monitoring, broad-spectrum antibiotic cover - Hypoxic Ischaemic Encephalopathy (HIE)
Phase 2Active not recruitingUniversity of Child Health Sciences and Children's Hospital, Lahore1102025-12-102025-12-26
Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates
Dexmedetomidine Infusion, Morphine Infusion - Hypoxic Ischemic Brain Injury, Neonatal Encephalopathy
Phase 2Not yet recruitingIpsita Goswami502025-07-012025-05-22
Hypertonic Lactate After Cardiac Arrest
Sodium Lactate Solution - Cardiac Arrest, Ischemia Reperfusion Injury
Phase 2RecruitingErasme University Hospital1252025-02-192025-02-21
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
Sildenafil, Ora-Blend - Neonatal Encephalopathy
Phase 2RecruitingPia Wintermark602024-07-012026-09-17
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Normal Saline along with standard treatment, Sovateltide along with standard treatment - Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia
Phase 2RecruitingPharmazz, Inc.402023-09-062025-12-31
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Burst Suppression EEG Target Intravenous Anesthesia, Seizure Suppression EEG Target Intravenous Anesthesia - Hypoxia-Ischemia, Brain, Heart Arrest
Phase 2RecruitingUniversity of California, San Francisco302023-08-072026-07-29
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
RLS-0071, Placebo - Hypoxic-Ischemic Encephalopathy
Phase 2 / Phase 3RecruitingReAlta Life Sciences, Inc.1732023-07-272026-11-05
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Levetiracetam Injection, Phenobarbital Sodium Injection - Neonatal Seizure, Neonatal Encephalopathy
Phase 2RecruitingUniversity of California, San Diego1332023-03-242026-10-15
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain
Phase 1 / Phase 2RecruitingUniversity of Calgary122023-01-012026-05-01
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
Dexmedetomidine Hydrochloride, Morphine Sulfate - Hypoxic-Ischemic Encephalopathy, Pain
Phase 2CompletedUniversity of Utah502022-06-202026-03-06
Brain Oxygenation-II
Intervention for cerebral hypoxia - Cerebral Hypoxia
Phase 2UnknownValerie Chock, M.D., M.S. Epi1002022-04-072024-04-18
Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease
Hypoxic Gas Mixture - Parkinson Disease, Effect of Drug
Phase 1 / Phase 2CompletedRadboud University Medical Center292022-02-222023-07-21
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
HB-adMSCs - Traumatic Brain Injury
Phase 1 / Phase 2CompletedHope Biosciences LLC242020-01-012026-11-09
Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy
HPDSC, Cord blood - Severe Hypoxic-ischemic Encephalopathy
Phase 2WithdrawnNew York Medical College2019-12-012021-02-23
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
TAK-935, Placebo - Epilepsy, Dravet Syndrome
Phase 2CompletedTakeda1412018-08-082026-09-14
Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study
Intravenous Levetiracetam - Neonatal Seizures
Phase 2CompletedUniversity Hospital, Tours182018-02-272025-12-30

Showing 20 of 42. Sign in to see all of them.

Narrower conditions

Hypoxia-Ischemia, Brain (37)  ·  Asphyxia Neonatorum (6)  ·  Hypothermia (4)  ·  Asphyxia (3)  ·  Brain Injuries (3)  ·  Brain Injuries, Traumatic (3)  ·  Heart Arrest (3)  ·  Seizures (3)  ·  Cerebral Palsy (2)  ·  Hypoxia (2)  ·  Lymphoma, Follicular (2)  ·  Stroke (2)  ·  Agnosia (1)  ·  Autonomic Nervous System Diseases (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (42)  ·  Signs and Symptoms (42)  ·  Signs and Symptoms, Respiratory (42)  ·  Brain Diseases (41)  ·  Central Nervous System Diseases (41)  ·  Nervous System Diseases (41)  ·  Hypoxia (40)  ·  Cardiovascular Diseases (38)  ·  Cerebrovascular Disorders (38)  ·  Vascular Diseases (38)  ·  Brain Ischemia (37)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8)  ·  Neurologic Manifestations (7)  ·  Wounds and Injuries (7)

Interventions

Hypothermia, Induced (3)  ·  Lasers, Gas (2)  ·  Saline Solution (2)  ·  Sildenafil Citrate (2)  ·  Topiramate (2)  ·  2-iminobiotin (1)  ·  Baclofen (1)  ·  Bumetanide (1)  ·  Cerebrovascular Circulation (1)  ·  Clonidine (1)  ·  Cool-Down Exercise (1)  ·  Core Binding Factors (1)  ·  Darbepoetin alfa (1)  ·  Dexmedetomidine (1)  ·  Dobutamine (1)

Sponsors

University Hospitals Bristol and Weston NHS Foundation Trust (2)  ·  University of California, San Francisco (2)  ·  University of Utah (2)  ·  Zhengzhou University (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Children's Hospital of Fudan University (1)  ·  Erasme University Hospital (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Hope Biosciences LLC (1)  ·  Ipsita Goswami (1)  ·  Johns Hopkins University (1)  ·  Kristin R Hoffman (1)  ·  Loewenstein Hospital (1)

Countries

United States (15)  ·  Canada (5)  ·  China (4)  ·  France (3)  ·  Netherlands (3)  ·  United Kingdom (3)  ·  Egypt (2)  ·  India (2)  ·  Israel (2)  ·  Australia (1)  ·  Belgium (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Italy (1)  ·  New Zealand (1)

Top investigators

Changlian Zhu, MD, PhD (2)  ·  Mariana Baserga, MD (2)  ·  Marianne Thoresen, Professor (2)  ·  Anil Gulati (1)  ·  Balraj Guhan, MD (1)  ·  Charles S Cox, MD (1)  ·  Cynthia M Sharpe, M.D. (1)  ·  Dorothea D Jenkins, MD (1)  ·  Edilberto Amorim, MD (1)  ·  Emmanuel Cuny, Professor (1)  ·  Estelle B Gauda, MD (1)  ·  Filippo Annoni, MD (1)  ·  Geraldine Favrais, Dr (1)  ·  Ipsita Goswami, MD (1)

Results publications

PMID 24524452, PMID 15199405, PMID 15607598, PMID 15607599, PMID 19172693, PMID 19883750, PMID 20385632, PMID 20631189, PMID 22805873, PMID 22950861, PMID 23133515, PMID 23897243, PMID 24473179, PMID 25765333, PMID 25794112, PMID 27126393, PMID 27535166, PMID 27614933, PMID 27632779, PMID 28949952, PMID 29016557, PMID 29769612, PMID 30661082, PMID 30679288, PMID 31155392, PMID 31261373, PMID 32813884, PMID 33362471, PMID 34482377, PMID 34764335, PMID 35836147, PMID 35841234, PMID 35995129, PMID 37422495, PMID 38902120, PMID 39498807, PMID 40983658

NIH funding

2014 (1), 2017 (1), 2018 (1), 2023 (1), 2025 (1), R01HD038600 (1), R01NS038062 (1)